Minor Histocompatibility Antigens: Molecular Barriers for Successful Tissue Transplantation

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4419-8999-4_7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A new second locus HL-A antigen in linkage disequilibrium with HL-A2 in cantonese chinese.

  2008cited by this paper
• Responses against antigens encoded by theH-3 histocompatibility locus: Antigens stimulating class I MHC- and class II MHC-restricted T cells are encoded by separate genes

  2006cited by this paper
• Complexity at the mouse minor histocompatibility locusH-4

  2004cited by this paper
• Nomenclature for factors of the HLA system 1984

  2004cited by this paper
• Genetic polymorphism of β2-microglobulin (B2m) maps to the H-3 region of chromosome 2

  2004cited by this paper
• An unexpectedly labile mitochondrially encoded protein is required for Mta expression

  2004cited by this paper
• Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse

  2003cited by this paper
• A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen

  2003cited by this paper
• Second Class Minors

  2003cited by this paper
• Targeting alloreactive T cells to hematopoietic system specific minor histocompatibility antigens for cellular immunotherapy of hematological malignancies after stem cell transplantation.

  2002cited by this paper
• The immunogenomics of minor histocompatibility antigens

  2002cited by this paper
• Minor histocompatibility antigens: molecular targets for adoptive cellular immunotherapy

  2002cited by this paper
• How H13 Histocompatibility Peptides Differing by a Single Methyl Group and Lacking Conventional MHC Binding Anchor Motifs Determine Self-Nonself Discrimination1

  2002cited by this paper
• The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

  2002cited by this paper
• Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire.

  2002cited by this paper
• Genetics of the immune response: identifying immune variation within the MHC and throughout the genome

  2002cited by this paper
• The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

  2002cited by this paper
• Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens.

  2002cited by this paper
• Ligands for murine NKG2D display heterogeneous binding behavior.

  2002cited by this paper
• The model B6dom1 minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene

  2002cited by this paper
• ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

  2001cited by this paper
• The Sequence of the Human Genome

  2001cited by this paper
• The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing

  2001cited by this paper
• Regulation of Cutaneous Malignancy by γδ T Cells

  2001cited by this paper
• Distinguishing Self from Nonself: Immunogenicity of the Murine H47 Locus Is Determined by a Single Amino Acid Substitution in an Unusual Peptide1

  2001cited by this paper
• The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein

  2001cited by this paper
• Generation of antigen-specific, lacZ-inducible T-cell hybrids.

  2001cited by this paper
• Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation.

  2001cited by this paper
• Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

  2001cited by this paper
• Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

  2001cited by this paper
• Polymorphisms in the coding region of mtDNA and effects on clinical outcome of unrelated bone marrow transplantation

  2001cited by this paper
• Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.

  2001cited by this paper
• The major substrates for TAP in vivo are derived from newly synthesized proteins

  2000cited by this paper
• UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.

  2000cited by this paper
• Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens.

  2000cited by this paper
• Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens.

  2000cited by this paper
• The Human UTY Gene Encodes a Novel HLA-B8-Restricted H-Y Antigen1

  2000cited by this paper
• Application of T cell immunotherapy for human viral and malignant diseases.

  2000cited by this paper
• DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection.

  2000cited by this paper
• Double Role of HLA in Organ Transplantation

  2000cited by this paper
• Rapid degradation of a large fraction of newly synthesized proteins by proteasomes

  2000cited by this paper
• The nuclear DEAD box RNA helicase p68 interacts with the nucleolar protein fibrillarin and colocalizes specifically in nascent nucleoli during telophase.

  2000cited by this paper
• Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

  2000cited by this paper
• Molecular modeling of the minor histocompatibility antigen HA-1 peptides binding to HLA-A alleles.

  2000cited by this paper
• Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages

  2000cited by this paper
• Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism.

  1999cited by this paper
• Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB

  1999cited by this paper
• Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.

  1999cited by this paper
• A potent oligosaccharyl transferase inhibitor that crosses the intracellular endoplasmic reticulum membrane.

  1999cited by this paper
• Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique.

  1999cited by this paper
• A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia

  1999cited by this paper
• Effect of N-linked glycosylation on glycopeptide and glycoprotein structure.

  1999cited by this paper
• Much ado about minor histocompatibility antigens.

  1998cited by this paper
• The molecular and functional characterization of a dominant minor H antigen, H60.

  1998cited by this paper
• Coordinate regulation of complex T cell populations responding to bacterial infection.

  1998cited by this paper
• Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA.

  1998cited by this paper
• Initiation of Protein Synthesis in Mammalian Cells with Codons Other Than AUG and Amino Acids Other Than Methionine

  1998cited by this paper
• Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.

  1998cited by this paper
• Non-traditionally derived CTL epitopes: exceptions that prove the rules?

  1998cited by this paper
• MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL.

  1998cited by this paper
• The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

  1998cited by this paper
• Immunodominant minor histocompatibility antigens: the major ones.

  1998cited by this paper
• Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex.

  1998cited by this paper
• Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.

  1998cited by this paper
• Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22.

  1998cited by this paper
• Identification of the rat maternally transmitted minor histocompatibility antigen.

  1997cited by this paper
• Why do some females reject males? The molecular basis for male-specific graft rejection

  1997cited by this paper
• Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.

  1997cited by this paper
• The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition.

  1997cited by this paper
• Immunodominant and subdominant CTL responses to Listeria monocytogenes infection.

  1997cited by this paper
• Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex.

  1997cited by this paper
• MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses

  1997cited by this paper
• Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.

  1997cited by this paper
• HNMP-1: A Novel Hematopoietic and Neural Membrane Protein Differentially Regulated in Neural Development and Injury

  1997cited by this paper
• The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning.

  1997cited by this paper
• An H–YDb epitope is encoded by a novel mouse Y chromosome gene

  1996cited by this paper
• Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins.

  1996cited by this paper
• The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3.

  1996cited by this paper
• Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.

  1996cited by this paper
• The preferential cytolytic T lymphocyte response to immunodominant minor histocompatibility antigen peptides.

  1996cited by this paper
• Needles in haystacks: identifying specific peptide antigens for T cells.

  1996cited by this paper
• A genetic linkage map of mouse chromosome 2 extending from thrombospondin to paired box gene 1, including the H3 minor histocompatibility complex.

  1996cited by this paper
• Identification of a mouse male-specific transplantation antigen, H-Y

  1995cited by this paper
• Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein.

  1995cited by this paper
• Asparagine-linked glycosylation: specificity and function of oligosaccharyl transferase.

  1995cited by this paper
• A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells

  1995cited by this paper
• Identification of a graft versus host disease-associated human minor histocompatibility antigen.

  1995cited by this paper
• Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides.

  1995cited by this paper
• LacZ inducible, antigen/MHC-specific T cell hybrids.

  1994cited by this paper
• Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones.

  1994cited by this paper
• The murine Xe169 gene escapes X–inactivation like its human homologue

  1994cited by this paper
• Isolation and characterization of XE169, a novel human gene that escapes X-inactivation.

  1994cited by this paper
• The original pink-eyed dilution mutation (p) arose in Asiatic mice: implications for the H4 minor histocompatibility antigen, Myod1 regulation and the origin of inbred strains.

  1994cited by this paper
• The functional basis of minor histocompatibility loci.

  1993cited by this paper
• DbpA: a DEAD box protein specifically activated by 23s rRNA.

  1993cited by this paper
• T CELL SUBSETS REQUIRED FOR IN VIVO AND IN VITRO RESPONSES TO SINGLE AND MULTIPLE MINOR HISTOCOMPATIBILITY ANTIGENS

  1992cited by this paper
• Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

  1992cited by this paper
• What are minor histocompatibility loci? A new look at an old question.

  1992cited by this paper
• Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.

  1992cited by this paper
• H-2M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse.

  1991cited by this paper

• Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residues.

  2008cites this paper
• Minor Histocompatibility Antigens: Molecular targets for immunomodulation in tissue transplantation and tumor therapy

  2005cites this paper